Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon

被引：17
|
作者：
Mariani, Leticia G. [1 ,2 ]
Schmitt, Ismael R. [1 ]
Garcia, Clotilde D. [3 ,4 ]
Kiszewski, Ana E. [1 ,2 ,4 ]
机构：
[1] Irmandade Santa Casa Misericordia Porto Alegre, Dermatol Serv, Porto Alegre, RS, Brazil
[2] Irmandade Santa Casa Misericordia Porto Alegre, Hosp Crianca Santo Antonio, Dermatol Pediat Unit, Porto Alegre, RS, Brazil
[3] Irmandade Santa Casa Misericordia Porto Alegre, Hosp Crianca Santo Antonio, Pediat Nefrol Serv, Porto Alegre, RS, Brazil
[4] Univ Fed Ciencias Saude Porto Alegre, Dept Internal Med, Porto Alegre, RS, Brazil
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷 / 08期
关键词：
VINCRISTINE;
D O I：
10.1002/pbc.27810
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon
    Wang, Zuopeng
    Li, Kai
    Dong, Kuiran
    Xiao, Xianmin
    Zheng, Shan
    PEDIATRIC BLOOD & CANCER, 2014, 61 (08) : 1518 - 1519
  • [2] Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon
    Chiu, Yvonne E.
    Drolet, Beth A.
    Blei, Francine
    Carcao, Manuel
    Fangusaro, Jason
    Kelly, Michael E.
    Krol, Alfons
    Lofgren, Sabra
    Mancini, Anthony J.
    Metry, Denise W.
    Recht, Michael
    Silverman, Robert A.
    Tom, Wynnis L.
    Pope, Elena
    PEDIATRIC BLOOD & CANCER, 2012, 59 (05) : 934 - 938
  • [3] KAPOSIFORM HEMANGIOENDOTHELIOMA AND REFRACTORY KASABACH-MERRITT PHENOMENON TREATED WITH SIROLIMUS
    Eren, Tuba
    Cakir, Fatma Betul
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S585 - S585
  • [4] Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
    Cabrera, Trevor B.
    Speer, Allison L.
    Greives, Matthew R.
    Goff, Donna A.
    Menon, Neethu M.
    Reynolds, Eric W.
    AJP REPORTS, 2020, 10 (04): : E390 - E394
  • [5] Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants
    Wang, Yuan
    Kong, Liangliang
    Sun, Buhao
    Cui, Jie
    Shen, Weimin
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (04) : 1074 - 1077
  • [6] Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon
    Pati, Sananda
    Das, Mrinal Kanti
    Rana, Akshay
    Das, Emilee
    Sarkar, Soumyadeep
    Sherpa, Norbu
    Datta, Supratim
    INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (11): : 1142 - 1144
  • [7] Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon: From Vincristine to Sirolimus
    Jahnel, J.
    Lackner, H.
    Reiterer, F.
    Urlesberger, B.
    Urban, C.
    KLINISCHE PADIATRIE, 2012, 224 (06): : 395 - 397
  • [8] Successful Treatment of Kasabach-Merritt Phenomenon Arising From Kaposiform Hemangioendothelioma by Sirolimus
    Wang, Zuopeng
    Li, Kai
    Dong, Kuiran
    Xiao, Xianmin
    Zheng, Shan
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (01) : 72 - 73
  • [9] SIROLIMUS FOR LIFE-THREATENING KAPOSIFORM HEMANGIOENDOTHELIOMA WITH KASABACH-MERRITT PHENOMENON
    Kim, Ji Yoon
    Kim, Sung Eun
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S75 - S75
  • [10] Abdominal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon
    不详
    JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (01) : 95 - 95
12345